Dividendos de Lushang Freda PharmaceuticalLtd
Dividendo controles de criterios 2/6
Lushang Freda PharmaceuticalLtd is a dividend paying company with a current yield of 1.47% that is well covered by earnings.
Información clave
1.5%
Rentabilidad por dividendo
-0.3%
Rendimiento de la recompra
| Rendimiento total para el accionista | 1.2% |
| Rendimiento futuro de los dividendos | 2.3% |
| Crecimiento de los dividendos | 5.5% |
| Próxima fecha de pago de dividendos | n/a |
| Fecha ex dividendo | n/a |
| Dividendo por acción | CN¥0.100 |
| Ratio de pago | 63% |
Últimas actualizaciones de dividendos
No hay actualizaciones
Recent updates
Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Doing What It Can To Lift Shares
Jun 21
Is Now An Opportune Moment To Examine Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)?
Apr 16Lushang Freda PharmaceuticalLtd's (SHSE:600223) Solid Earnings May Rest On Weak Foundations
Mar 28Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223) Stock Rockets 26% As Investors Are Less Pessimistic Than Expected
Mar 04A Look At The Fair Value Of Lushang Freda Pharmaceutical Co.,Ltd. (SHSE:600223)
Feb 27Estabilidad y crecimiento de los pagos
Obteniendo datos sobre dividendos
Dividendo estable: 600223 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Dividendo creciente: 600223's dividend payments have increased, but the company has only paid a dividend for 5 years.
Rentabilidad por dividendo vs. Mercado
| Rentabilidad por dividendo de Lushang Freda PharmaceuticalLtd vs. Mercado |
|---|
| Segmento | Rentabilidad por dividendo |
|---|---|
| Empresa (600223) | 1.5% |
| Suelo de mercado 25% (CN) | 0.6% |
| Techo de mercado 25% (CN) | 2.2% |
| Media de la industria (Real Estate) | 2.3% |
| Analista de previsiones (600223) (hasta 3 años) | 2.3% |
Dividendo destacado: 600223's dividend (1.47%) is higher than the bottom 25% of dividend payers in the CN market (0.57%).
Alto dividendo: 600223's dividend (1.47%) is low compared to the top 25% of dividend payers in the CN market (2.22%).
Pago de beneficios a los accionistas
Cobertura de los beneficios: With its reasonable payout ratio (62.8%), 600223's dividend payments are covered by earnings.
Pago en efectivo a los accionistas
Cobertura de flujo de caja: With its high cash payout ratio (179.7%), 600223's dividend payments are not well covered by cash flows.